Rheumatoid Arthritis-associated Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis-associated Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial evaluating inhaled AP01 for progressive pulmonary fibrosis is currently recruiting, with no results yet reported.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis
This trial update describes the construction of a clinical cohort and evaluation of the therapeutic effects of integrated traditional Chines…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Clinical trial update indicating ongoing collection of airway, blood, and/or urine specimens from participants for research studies.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: "Matrix Metalloproteinases 7 and 9 in Rheumatoid Arthritis Patients With Interstitial Lung Disease"
A clinical trial sponsored by Assiut University is evaluating the roles of matrix metalloproteinases MMP-7 and MMP-9 in patients with rheuma…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation Context [NA]
This ClinicalTrials.gov entry reports that an exercise program for adults with diffuse interstitial lung disease within a pulmonary rehabili…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease [Phase 2]
This is a Phase II randomized, double-blind, placebo-controlled trial to evaluate safety, tolerability, efficacy, and pharmacokinetics of Ge…